These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Probiotics in functional bowel disorders. Hod K; Ringel Y Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):89-97. PubMed ID: 27048900 [TBL] [Abstract][Full Text] [Related]
65. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence. Quigley EM J Clin Gastroenterol; 2015; 49 Suppl 1():S60-4. PubMed ID: 26447967 [TBL] [Abstract][Full Text] [Related]
66. A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial. Fan YJ; Chen SJ; Yu YC; Si JM; Liu B J Zhejiang Univ Sci B; 2006 Dec; 7(12):987-91. PubMed ID: 17111468 [TBL] [Abstract][Full Text] [Related]
67. Treatment of irritable bowel syndrome with probiotics: growing evidence. Bixquert M Indian J Med Res; 2013; 138(2):175-7. PubMed ID: 24056591 [No Abstract] [Full Text] [Related]
68. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy]. Konturek PC; Zopf Y MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952 [TBL] [Abstract][Full Text] [Related]
69. [Clinical observation on acupuncture combined with microorganism pharmaceutical preparations for treatment of irritable bowel syndrome of constipation type]. Long ZR; Yu CH; Yang Y; Wang HN; Chi XX Zhongguo Zhen Jiu; 2006 Jun; 26(6):403-5. PubMed ID: 16813181 [TBL] [Abstract][Full Text] [Related]
71. Irritable bowel syndrome; update on pathophysiology and management. Quigley EM; Craig OF Turk J Gastroenterol; 2012 Aug; 23(4):313-22. PubMed ID: 22965501 [TBL] [Abstract][Full Text] [Related]
72. He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome. Pokrotnieks J; Sitkin S Neurogastroenterol Motil; 2024 Aug; 36(8):e14805. PubMed ID: 38651671 [TBL] [Abstract][Full Text] [Related]
73. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427 [TBL] [Abstract][Full Text] [Related]
74. What you must know before you recommend a probiotic. Clauson ER; Crawford P J Fam Pract; 2015 Mar; 64(3):151-5. PubMed ID: 25789349 [TBL] [Abstract][Full Text] [Related]
75. Probiotics in the management of functional bowel disorders: promise fulfilled? Quigley EM Gastroenterol Clin North Am; 2012 Dec; 41(4):805-19. PubMed ID: 23101688 [TBL] [Abstract][Full Text] [Related]
76. Treatment of irritable bowel syndrome with Saccharomyces boulardii. Guslandi M J Clin Gastroenterol; 2011 Sep; 45(8):740-1; author reply 741-2. PubMed ID: 21555955 [No Abstract] [Full Text] [Related]
77. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial. Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575 [TBL] [Abstract][Full Text] [Related]
78. Cao YN; Feng LJ; Wang BM; Jiang K; Li S; Xu X; Wang WQ; Zhao JW; Wang YM Saudi J Gastroenterol; 2018; 24(1):59-66. PubMed ID: 29451186 [TBL] [Abstract][Full Text] [Related]
79. Microbial-gut interactions in health and disease. Irritable bowel syndrome. Verdu EF; Collins SM Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):315-21. PubMed ID: 15123072 [TBL] [Abstract][Full Text] [Related]
80. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Whelan K; Quigley EM Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]